Clorox (CLX)
NYSE: CLX · Household Products · Oakland, CA
Our rating: Positive
Positive reaffirmed at $93.80, moderate conviction, November 3, 2026.
Breaks if: The positive call is broken if revenue declines more than 2% year-over-year in the next annual filing, or if free-cash-flow margin slips below 9% for two consecutive quarterly reporting periods — either would confirm the flat top line has become a structural earnings problem rather than a temporary lull. A drawdown of 20% or more over the next twelve months without any fundamental improvement would signal the market sees deterioration not yet visible in the reported figures.
Key figures
| Market value | $12.7B |
|---|---|
| Revenue, last 12 months | n/a |
| Net income, last 12 months | n/a |
| Free cash flow, last 12 months | n/a |
| Price to earnings | n/a |
| Free cash flow yield | n/a |
| Dividend yield | 4.8% |
| Operating margin | n/a |
| Return on equity | n/a |
| Beta to the S&P 500 | 0.23 |
| Volatility, annualized | 26.8% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $1.9B | 33.3% | $1.39 | $105M |
| March 31, 2026 | $1.7B | 0.1% | $1.54 | −$165M |
| December 31, 2025 | $1.7B | −0.8% | $1.29 | $269M |
| September 30, 2025 | $1.4B | −18.9% | $0.65 | $57M |
| June 30, 2025 | $2.0B | 4.5% | $2.68 | $219M |
| March 31, 2025 | $1.7B | −8.0% | $1.50 | $233M |
| December 31, 2024 | $1.7B | −15.3% | $1.54 | $127M |
| September 30, 2024 | $1.8B | 27.1% | $0.80 | $182M |
14 ledger entries and 36 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.